• FirefoxInstall the new Firefox »
  •  Dow Down0.54% Nasdaq Down0.44%

    More On ONCY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    Oncolytics Biotech Inc. (ONCY)

    -NasdaqCM
    0.75 Down 0.02(1.99%) 12:48PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development11,935  17,417  31,538  
    Selling General and Administrative4,316  5,075  5,308  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (16,251) (22,493) (36,846)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes(16,070)(22,143)(36,500)
    Interest Expense -   -   -  
    Income Before Tax(16,070)(22,143)(36,500)
    Income Tax Expense6  5  31  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(16,075)(22,148)(36,531)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (16,075) (22,148) (36,531)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (16,075) (22,148) (36,531)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.